Cyclopharm Limited Share Price
Stocks
CYC
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
10:40:11 30/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.4250 AUD | +10.39% |
|
+13.33% | -56.63% |
| 29/10 | Cyclopharm Limited, Q3 2026 Earnings Call, Oct 29, 2026 | |
| 26/10 | Cyclopharm Limited Announces Retirement of Dianne Angus as Non-Executive Director, Effective November 30, 2026 | CI |
| Market Cap | 4.84Cr 3.41Cr 3.05Cr 2.82Cr 2.55Cr 4.76Cr 324.42Cr 34Cr 13Cr 169.79Cr 13Cr 13Cr 537.76Cr | P/E 2026 * |
-2.74x | P/E 2027 * | -4.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.84Cr 3.41Cr 3.05Cr 2.82Cr 2.55Cr 4.76Cr 324.42Cr 34Cr 13Cr 169.79Cr 13Cr 13Cr 537.76Cr | EV / Sales 2026 * |
1.3x | EV / Sales 2027 * | 1.03x |
| Free-Float |
51.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cyclopharm Limited
| 1 day | +10.39% | ||
| 1 week | +13.33% | ||
| Current month | -6.59% | ||
| 1 month | -6.59% | ||
| 3 months | -27.35% | ||
| 6 months | -41.38% | ||
| Current year | -56.63% |
| 1 week | 0.36 |  | 0.46 |
| 1 month | 0.33 | | 0.52 |
| Current year | 0.33 | | 1.29 |
| 1 year | 0.33 | | 1.29 |
| 3 years | 0.33 | | 2.5 |
| 5 years | 0.33 | | 3.15 |
| 10 years | 0.33 | | 3.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 21/10/2009 |
Jason Smith
DFI | Director of Finance/CFO | - | 26/02/2024 |
Mathew Farag
COO | Chief Operating Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
James McBrayer
BRD | Director/Board Member | 60 | 03/06/2008 |
Dianne Angus
BRD | Director/Board Member | 65 | 10/08/2021 |
Gregory King
BRD | Director/Board Member | - | 27/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/03/26 | Buy | Director | 21,052 | 0.0175% | ||
| 12/03/26 | Buy | Director | 5,263 | 0.0044% | ||
| 12/03/26 | Buy | Director | 21,052 | 0.0175% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.39% | +13.33% | -36.57% | -78.21% | 3.41Cr | |
| +0.71% | +4.82% | +27.02% | +64.39% | 26TCr | |
| +1.24% | +3.15% | +10.73% | +26.13% | 17TCr | |
| +1.03% | +1.11% | -16.52% | +73.28% | 16TCr | |
| +0.61% | -7.22% | -57.44% | -13.79% | 6.19TCr | |
| +2.90% | +4.83% | +14.21% | +53.04% | 5.44TCr | |
| +0.45% | +2.94% | -11.56% | -5.86% | 5.33TCr | |
| -0.18% | +4.18% | +26.50% | +76.27% | 5.11TCr | |
| -2.35% | -3.79% | +8.26% | +63.75% | 5.02TCr | |
| +0.67% | +5.37% | +39.77% | +96.14% | 4.72TCr | |
| Average | +1.47% | +2.21% | +0.44% | +35.51% | 9.03TCr | |
| Weighted average by Cap. | +0.71% | +2.44% | +7.26% | +50.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.72Cr 2.62Cr 2.34Cr 2.16Cr 1.96Cr 3.66Cr 249.31Cr 26Cr 10Cr 130.48Cr 9.83Cr 9.62Cr 413.26Cr | 4.72Cr 3.32Cr 2.98Cr 2.74Cr 2.48Cr 4.64Cr 316.33Cr 33Cr 13Cr 165.55Cr 12Cr 12Cr 524.35Cr |
| Net income | -1.74Cr -1.22Cr -1.1Cr -1.01Cr -91.57L -1.71Cr -116.61Cr -12Cr -4.82Cr -61Cr -4.6Cr -4.5Cr -193.3Cr | -1.24Cr -87.27L -78.17L -72.11L -65.26L -1.22Cr -83Cr -8.6Cr -3.43Cr -43Cr -3.28Cr -3.21Cr -137.75Cr |
| Net Debt | - | - |
Employees
104
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | A$0.4250 | +10.39% | 1,11,297 |
| 29/26/29 | A$0.3850 | +4.05% | 1,38,069 |
| 28/26/28 | A$0.3700 | 0.00% | 33,757 |
| 27/26/27 | A$0.3700 | -1.33% | 2,410 |
| 23/26/23 | A$0.3750 | +4.17% | 1,209 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2710USD
Average target price
0.7170USD
Spread / Average Target
+164.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CYC Stock
Select your edition
All financial news and data tailored to specific country editions
